Renal transplantation in lupus nephritis

C. Ponticelli, Gabriella Moroni

Research output: Contribution to journalArticle

Abstract

Most patients with systemic lupus erythematosus (SLE) are suitable candidates for renal transplantation. However, a number of them may present some disease-related problems. As cardiovascular disease is a leading cause of morbidity and mortality in SLE patients, a careful pretransplant cardiovascular screening is recommended. A search for antiphospholipid antibodies is also useful as the presence of these antibodies can cause an early graft thrombosis. The risk of recurrence of SLE nephritis after transplantation may range between 2 and 30%. In most cases recurrence is characterized by mild histologic lesions. Only rarely does it lead to graft failure. Postransplant immunosuppression does not differ from that used routinely. Whenever possible, a steroid-free immunosuppression should be scheduled to prevent iatrogenic toxicity in patients who have already received long-term steroid treatment. The results of kidney transplantation largely depend on the clinical conditions at transplantation. In patients with poor clinical status or receiving an aggressive immunosuppression it is advisable to postpone the transplant. When some selection criteria are respected, the results of renal trasplantation in SLE patients are at least as good as in other transplant recipients.

Original languageEnglish
Pages (from-to)95-98
Number of pages4
JournalLupus
Volume14
Issue number1
DOIs
Publication statusPublished - 2005

Fingerprint

Lupus Nephritis
Kidney Transplantation
Systemic Lupus Erythematosus
Immunosuppression
Transplants
Transplantation
Steroids
Recurrence
Antiphospholipid Antibodies
Patient Selection
Thrombosis
Cardiovascular Diseases
Morbidity
Kidney
Mortality
Antibodies

Keywords

  • Lupus nephritis
  • Recurrence
  • Renal transplantation
  • Systemic lupus erythematosus

ASJC Scopus subject areas

  • Immunology
  • Rheumatology

Cite this

Renal transplantation in lupus nephritis. / Ponticelli, C.; Moroni, Gabriella.

In: Lupus, Vol. 14, No. 1, 2005, p. 95-98.

Research output: Contribution to journalArticle

Ponticelli, C. ; Moroni, Gabriella. / Renal transplantation in lupus nephritis. In: Lupus. 2005 ; Vol. 14, No. 1. pp. 95-98.
@article{70c86ca58304490d99d4234426cff9ef,
title = "Renal transplantation in lupus nephritis",
abstract = "Most patients with systemic lupus erythematosus (SLE) are suitable candidates for renal transplantation. However, a number of them may present some disease-related problems. As cardiovascular disease is a leading cause of morbidity and mortality in SLE patients, a careful pretransplant cardiovascular screening is recommended. A search for antiphospholipid antibodies is also useful as the presence of these antibodies can cause an early graft thrombosis. The risk of recurrence of SLE nephritis after transplantation may range between 2 and 30{\%}. In most cases recurrence is characterized by mild histologic lesions. Only rarely does it lead to graft failure. Postransplant immunosuppression does not differ from that used routinely. Whenever possible, a steroid-free immunosuppression should be scheduled to prevent iatrogenic toxicity in patients who have already received long-term steroid treatment. The results of kidney transplantation largely depend on the clinical conditions at transplantation. In patients with poor clinical status or receiving an aggressive immunosuppression it is advisable to postpone the transplant. When some selection criteria are respected, the results of renal trasplantation in SLE patients are at least as good as in other transplant recipients.",
keywords = "Lupus nephritis, Recurrence, Renal transplantation, Systemic lupus erythematosus",
author = "C. Ponticelli and Gabriella Moroni",
year = "2005",
doi = "10.1191/0961203305lu2067oa",
language = "English",
volume = "14",
pages = "95--98",
journal = "Lupus",
issn = "0961-2033",
publisher = "SAGE Publications Ltd",
number = "1",

}

TY - JOUR

T1 - Renal transplantation in lupus nephritis

AU - Ponticelli, C.

AU - Moroni, Gabriella

PY - 2005

Y1 - 2005

N2 - Most patients with systemic lupus erythematosus (SLE) are suitable candidates for renal transplantation. However, a number of them may present some disease-related problems. As cardiovascular disease is a leading cause of morbidity and mortality in SLE patients, a careful pretransplant cardiovascular screening is recommended. A search for antiphospholipid antibodies is also useful as the presence of these antibodies can cause an early graft thrombosis. The risk of recurrence of SLE nephritis after transplantation may range between 2 and 30%. In most cases recurrence is characterized by mild histologic lesions. Only rarely does it lead to graft failure. Postransplant immunosuppression does not differ from that used routinely. Whenever possible, a steroid-free immunosuppression should be scheduled to prevent iatrogenic toxicity in patients who have already received long-term steroid treatment. The results of kidney transplantation largely depend on the clinical conditions at transplantation. In patients with poor clinical status or receiving an aggressive immunosuppression it is advisable to postpone the transplant. When some selection criteria are respected, the results of renal trasplantation in SLE patients are at least as good as in other transplant recipients.

AB - Most patients with systemic lupus erythematosus (SLE) are suitable candidates for renal transplantation. However, a number of them may present some disease-related problems. As cardiovascular disease is a leading cause of morbidity and mortality in SLE patients, a careful pretransplant cardiovascular screening is recommended. A search for antiphospholipid antibodies is also useful as the presence of these antibodies can cause an early graft thrombosis. The risk of recurrence of SLE nephritis after transplantation may range between 2 and 30%. In most cases recurrence is characterized by mild histologic lesions. Only rarely does it lead to graft failure. Postransplant immunosuppression does not differ from that used routinely. Whenever possible, a steroid-free immunosuppression should be scheduled to prevent iatrogenic toxicity in patients who have already received long-term steroid treatment. The results of kidney transplantation largely depend on the clinical conditions at transplantation. In patients with poor clinical status or receiving an aggressive immunosuppression it is advisable to postpone the transplant. When some selection criteria are respected, the results of renal trasplantation in SLE patients are at least as good as in other transplant recipients.

KW - Lupus nephritis

KW - Recurrence

KW - Renal transplantation

KW - Systemic lupus erythematosus

UR - http://www.scopus.com/inward/record.url?scp=13444266040&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=13444266040&partnerID=8YFLogxK

U2 - 10.1191/0961203305lu2067oa

DO - 10.1191/0961203305lu2067oa

M3 - Article

C2 - 15732296

AN - SCOPUS:13444266040

VL - 14

SP - 95

EP - 98

JO - Lupus

JF - Lupus

SN - 0961-2033

IS - 1

ER -